We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2009 by Sheba Medical Center.
Recruitment status was:  Enrolling by invitation
Sponsor:
ClinicalTrials.gov Identifier:
NCT00912067
First Posted: June 3, 2009
Last Update Posted: June 3, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sheba Medical Center
  Purpose
The purpose of this study is to evaluate the presence and manifestations of ocular graft versus host disease in adults that had hematopoietic stem cell transplantation in the past 3 years at the sheba medical center, Israel. As well as correlate the degree of the presentation to the therapeutic protocol (chemotherapy and irradiation).

Condition
Graft Versus Host Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 120
Study Start Date: July 2009
Groups/Cohorts
hematopoietic stem cell transplantation

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
adults after hematopoietic stem cell transplantation done at sheba medical center Israel during the last 3 years
Criteria

Inclusion Criteria:

  • after hematopoietic stem cell transplantation done at sheba medical center Israel
  • 3 month have past from transplantation but no more then 3 years

Exclusion Criteria:

  • transplantation done in the last 3 month or more than 3 years have past since
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00912067


Locations
Israel
Sheba Medical Center
Tel Hashomer, Israel, 52621
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: irina barequet, MD Sheba Medical Center
  More Information

Publications:
Responsible Party: Irina Barequet MD/PI, Sheba Medical Center
ClinicalTrials.gov Identifier: NCT00912067     History of Changes
Other Study ID Numbers: SHEBA-09-7085-IB-CTIL
First Submitted: June 1, 2009
First Posted: June 3, 2009
Last Update Posted: June 3, 2009
Last Verified: June 2009

Additional relevant MeSH terms:
Graft vs Host Disease
Immune System Diseases